RFA-DA-23-013 - NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Question and Answer "Office Hours" with NIH Staff for NIDA Racial Equity Initiative Funding Opportunities RFA-DA-23-013, RFA-DA-23-026, RFA-DA-23-028, RFA-DA-23-029, RFA-DA-23-031, RFA-DA-23-032, RFA-DA-23-061, RFA-DA-23-062 | NOT-DA-24-035 | NIDA | Jun 20, 2024 | n/a | R01, DP1, R34, R61/R33 |
Notice of Change to Key Dates for RFA-DA-23-013, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) | NOT-DA-22-072 | NIDA | Aug 23, 2022 | n/a | R01 |